Literature DB >> 11567663

Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis.

T K Nordt1, J Lohrmann, C Bode.   

Abstract

Increased expression of plasminogen activator inhibitor type 1 (PAI-1) is now considered as an independent risk factor for cardiovascular disease. Numerous biochemical factors have been found to regulate the expression of PAI-1 gene and the synthesis of PAI-1 protein. In the recent past, polymorphisms in the PAI-1 gene have been identified and their impact on PAI-1 expression has been characterized. This article will review the current knowledge of these PAI-1 gene polymorphisms (in cell culture epidemiological, and clinical studies) and their role in the development of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567663     DOI: 10.1016/s0049-3848(01)00292-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Maternal Thrombophilic and Hypofibrinolytic Genetic Variants in Idiopathic Recurrent Pregnancy Loss: a Continuing Mystery.

Authors:  Mahmoud Younis; Mohamed A M Ali; Doaa A Ghareeb; Rehab Youssef; Shadia A Fathy
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

2.  Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.

Authors:  Norma Torres-Carrillo; Nora Magdalena Torres-Carrillo; Gloria Esther Martínez-Bonilla; Mónica Vázquez-Del Mercado; Claudia Azucena Palafox-Sánchez; Edith Oregón-Romero; Ana Guilaisne Bernard-Medina; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

3.  Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease.

Authors:  Orhan Onalan; Gunay Balta; Ali Oto; Giray Kabakci; Lale Tokgozoglu; Kudret Aytemir; Cigdem Altay; Aytemiz Gurgey; Nasih Nazli
Journal:  J Thromb Thrombolysis       Date:  2007-08-25       Impact factor: 2.300

4.  Genetic and metabolic determinants of increased plasma plasminogen activator inhibitor-1 activity in children with renal transplants.

Authors:  Luis Aldámiz-Echevarría; Pablo Sanjurjo; Alfredo Vallo; Mireia Aguirre; Gustavo Pérez-Nanclares; Pilar Gimeno; Miguel Rueda; José Ignacio Ruiz; Juan Rodríguez-Soriano
Journal:  Pediatr Nephrol       Date:  2003-05-22       Impact factor: 3.714

5.  In black South Africans from rural and urban communities, the 4G/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time.

Authors:  Zelda de Lange; Dingeman C Rijken; Tiny Hoekstra; Karin R Conradie; Johann C Jerling; Marlien Pieters
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

6.  Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study.

Authors:  Manal S Fawzy; Eman A Toraih; Nagwa M Aly; Abeer Fakhr-Eldeen; Dahlia I Badran; Mohammad H Hussein
Journal:  BMC Cardiovasc Disord       Date:  2017-01-13       Impact factor: 2.298

7.  Association Between - 675 ID, 4G/5G PAI-1 Gene Polymorphism and Pregnancy Loss: A Systematic Review.

Authors:  Grazyna Adler; Emir Mahmutbegovic; Amina Valjevac; Mateusz A Adler; Nevena Mahmutbegovic; Krzysztof Safranow; Ewa Czerska; Anna Pawinska-Matecka; Iwona Ciechanowicz; Damir Marjanovic
Journal:  Acta Inform Med       Date:  2018-10

8.  Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco.

Authors:  Hind Hassani Idrissi; Wiam Hmimech; Brehima Diakite; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Meta Gene       Date:  2016-04-03

Review 9.  [Infarto agudo de miocardio: revisión sobre factores de riesgo, etiología, hallazgos angiográficos y desenlaces en pacientes jóvenes].

Authors:  Carlos A Dattoli-García; Cynthia N Jackson-Pedroza; Andrea L Gallardo-Grajeda; Rodrigo Gopar-Nieto; Diego Araiza-Garygordobil; Alexandra Arias-Mendoza
Journal:  Arch Cardiol Mex       Date:  2021-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.